Suppression of tuberculin skin reaction in healthy HTLV-I carriers from Japan.
about
Crusted scabies in association with human T-cell lymphotropic virus 1.Genes related to antiviral activity, cell migration, and lysis are differentially expressed in CD4(+) T cells in human t cell leukemia virus type 1-associated myelopathy/tropical spastic paraparesis patients.Modulation of T-cell responses to a recall antigen in human T-cell leukemia virus type 1-infected individualsInfluence of HTLV-1 on the clinical, microbiologic and immunologic presentation of tuberculosis.Peripheral blood mononuclear cells from individuals infected with human T-cell lymphotropic virus type 1 have a reduced capacity to respond to recall antigens.Enhanced inhibition of lymphocyte activation by Mycobacterium avium complex in human T lymphotrophic virus type I carriersInterference with immune function by HTLV-1.HTLV-1 modulates the frequency and phenotype of FoxP3+CD4+ T cells in virus-infected individuals.Tuberculosis incidence in a cohort of individuals infected with human T-lymphotropic virus type 1 (HTLV-1) in Salvador, Brazil.Dendritic cells in viral pathogenesis: protective or defective?Population differences in immune marker profiles associated with human T-lymphotropic virus type I infection in Japan and Jamaica.The epidemiology of HTLV-I infection.HTLV-1 and Adult T-Cell Leukemia/Lymphoma: A Review.Increased HTLV-I proviral DNA in HTLV-I-associated myelopathy: a quantitative polymerase chain reaction study.HLA DRB1*DQB1* haplotype in HTLV-I-associated familial infective dermatitis may predict development of HTLV-I-associated myelopathy/tropical spastic paraparesis.Interaction of human immunodeficiency virus type 1, human T-cell leukemia/lymphoma virus type I (HTLV-I), and HTLV-II with in vitro-generated dendritic cells.Possible origin of adult T-cell leukemia/lymphoma cells from human T lymphotropic virus type-1-infected regulatory T cells.HCV/HTLV coinfection: Does HTLV-1 interfere in the natural history of HCV-related diseases?Human T-cell leukemia virus type I(HTLV-I) infection of T cells bearing T-cell receptor gamma delta: effects of HTLV-I infection on cytotoxicity.Influence of human T-cell lymphotropic virus type 1 (HTLV-1) Infection on laboratory parameters of patients with chronic hepatitis C virus.Increased prevalence of HTLV-I infection in patients with hepatocellular carcinoma associated with hepatitis C virus.Reduced efficacy of treatment of strongyloidiasis in HTLV-I carriers related to enhanced expression of IFN-gamma and TGF-beta1.Patterns of serum type 1 and type 2 immune markers in healthy carriers of HTLV-I.Successful bone marrow transplantation and treatment of BCG infection in two patients with severe combined immunodeficiency.Depletion and impaired interferon-alpha-producing capacity of blood plasmacytoid dendritic cells in human T-cell leukaemia virus type I-infected individuals.Decreased reactivity to PPD among HTLV-I carriers in relation to virus and hematologic status.The relationship of FOXP3 expression and clinicopathological characteristics in adult T-cell leukemia/lymphoma.A case of diffuse panbronchiolitis (DPB) in a patient positive for HTLV-1.Mortality among inhabitants of an HTLV-I endemic area in Japan.Clinicopathological features of cutaneous lesions of adult T-cell leukaemia/ lymphoma.Improvement of quality of life after splenectomy in an HTLV-I carrier with T-cell prolymphocytic leukemia.[Dermatologic lesions in patients infected with the human T-cell lymphotropic virus type 1 (HTLV-1)].Adult T-Cell Leukemia (ATL): Clinical, Pathological and Virological Findings in Two Cases with Unusual Features
P2860
Q33605617-EF24AA6C-E050-498A-8BCD-47254FE5E43AQ33713794-8F07E80B-8F0B-4795-8CC2-A6119AE8C254Q33997886-8C7D414E-C77E-4E19-AD38-CAC56542433DQ34394609-DA8B5BD5-7A0B-48B8-A4C2-27866AFFC8C5Q34601530-17388D22-FF94-4AC0-BFE1-49124D086C56Q35534455-497BCC31-D267-495F-84F8-FCB09F582548Q35843822-1727D47A-F413-4F51-9C61-035B9AA87D9FQ36112549-660433D0-F044-4B46-AAED-DD53F33D36BAQ36137104-473A66DE-BECB-4A92-8284-10A03D838C3BQ36207868-871AC112-9683-42DF-BB8D-A96AC9E8A04AQ37241473-FA81FBA3-2617-4F54-B7E0-5918E4D6C4E4Q37253315-712B0CF9-799C-473C-ABCB-860E0A6782E1Q38897817-9A1FE625-1D6C-4C54-8448-19E92D1CECBDQ39138593-719562C9-C8BE-4B3E-BA0D-24CBDA52D161Q39156687-5C6CB6B6-70D5-4474-879A-F1D1A8361C37Q39809710-16A00596-D19D-4BF4-BB80-0590776609BFQ40383822-E170F408-6DC3-47E7-95EB-9064DEBA93AAQ40736143-435701E7-C7F9-4AAE-B2A6-5C6FC60B8C7FQ41641860-72BBB29B-9EFC-487A-B089-F911231B442EQ42995255-9A24F188-86A2-48FA-B2FB-CBAE254D6009Q43039863-07245EBE-ED5A-4490-B22F-24032F677D32Q43904336-4F952876-65D9-4E4F-80F7-060F55950AE8Q44923997-F1CEA56E-B243-4129-AF18-D08D72C9E38BQ45149081-8873FEAE-D931-4D92-A26F-A890715374C5Q45639637-3623F160-218E-47F3-82E6-838A0F538117Q45776535-6EA1CBEF-0182-4012-8C68-E97766B2D5E4Q46774844-E6832058-FA3A-4198-9CC9-19BCD3607942Q47926382-32F03CC5-76CF-4E41-B372-F46C4BE558D7Q50604367-FD457363-22D2-401E-A856-48817FC66E65Q50776966-9F6796D2-1392-4D77-B18C-FB8E447A55B6Q53534980-F09A315C-0833-4527-8DDD-DFD89BAA0DA9Q55239509-5F9A5ACF-C6EA-44ED-945F-539C8F192A55Q58276669-01A45B19-A114-4259-A89B-52C5582D9944
P2860
Suppression of tuberculin skin reaction in healthy HTLV-I carriers from Japan.
description
1988 nî lūn-bûn
@nan
1988年の論文
@ja
1988年論文
@yue
1988年論文
@zh-hant
1988年論文
@zh-hk
1988年論文
@zh-mo
1988年論文
@zh-tw
1988年论文
@wuu
1988年论文
@zh
1988年论文
@zh-cn
name
Suppression of tuberculin skin reaction in healthy HTLV-I carriers from Japan.
@en
type
label
Suppression of tuberculin skin reaction in healthy HTLV-I carriers from Japan.
@en
prefLabel
Suppression of tuberculin skin reaction in healthy HTLV-I carriers from Japan.
@en
P2093
P2860
P356
P1476
Suppression of tuberculin skin reaction in healthy HTLV-I carriers from Japan.
@en
P2093
E Shishime
J Ishizaki
N Tachibana
P2860
P304
P356
10.1002/IJC.2910420605
P577
1988-12-01T00:00:00Z